(Q35273120)

7 August 2017

1 reference

title

Current concepts in the pathophysiology of hepatic encephalopathy (English)

1 reference

7 August 2017

1 reference

P. Ferenci

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1360897

18 September 2022

A. Püspök

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1360897

18 September 2022

P. Steindl

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1360897

18 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1360897

18 September 2022

publication date

1 September 1992

1 reference

European Journal of Clinical Investigation

7 August 2017

published in

1 reference

7 August 2017

volume

22

1 reference

7 August 2017

issue

9

1 reference

7 August 2017

page(s)

573-581

1 reference

Potential toxins of acute liver failure and their effects on blood-brain barrier permeability.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Digoxin-like immunoreactive substances in severe acute liver disease due to viral hepatitis and paracetamol overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Blood-brain neutral amino acid transport activity is increased after portacaval anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Regional blood-brain barrier permeability to amino acids after portacaval anastomosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Evidence for the role of ammonia in the intracerebral transfer and metabolism of tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Regional cerebral glucose utilization in rats with portacaval anastomosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Blood and brain concentrations of mercaptans in hepatic and methanethiol induced coma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Mechanism of the excessive sedative response of cirrhotics to benzodiazepines: model experiments with triazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Supersensitivity of Benzodiazepine Receptors in Hepatic Encephalopathy Due to Fulminant Hepatic Failure in the Rat: Reversal by a Benzodiazepine Antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Postsynaptic gamma-aminobutyric acid receptors in hepatic coma following portacaval shunt and hepatic artery ligation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Brain gamma-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma gamma-aminobutyric acid-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Affinities and densities of high-affinity [3H]muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy. No evidence for increased GABA-transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Experimental Hepatic Encephalopathy: Changes in the Binding of γ-Aminobutyric Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Decrease of brain zinc in experimental hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Occurrence of "natural" benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Changes in brain metabolism during hyperammonemia and acute liver failure: results of a comparative 1H-NMR spectroscopy and biochemical investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

False neurotransmitters and hepatic failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide—induced acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Changes in brain catecholamine levels in human cirrhotic hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Cerebral blood flow and metabolism in hepatic cirrhosis before and after portacaval shunt operation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

Hyperammonaemia does not impair brain function in the absence of net glutamine synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1992.TB01508.X

10.1111/J.1365-2362.1992.TB01508.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference